Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B6T5
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 9 |
GO:0005509 | calcium ion binding | 5 | 9 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043169 | cation binding | 3 | 9 |
GO:0046872 | metal ion binding | 4 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 174 | 178 | PF00656 | 0.405 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.413 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.413 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.213 |
CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.213 |
CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.286 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.377 |
CLV_Separin_Metazoa | 35 | 39 | PF03568 | 0.266 |
DEG_APCC_DBOX_1 | 262 | 270 | PF00400 | 0.264 |
DOC_CYCLIN_RxL_1 | 205 | 213 | PF00134 | 0.474 |
DOC_CYCLIN_RxL_1 | 259 | 268 | PF00134 | 0.376 |
DOC_CYCLIN_RxL_1 | 50 | 60 | PF00134 | 0.281 |
DOC_MAPK_gen_1 | 87 | 97 | PF00069 | 0.511 |
DOC_PP2B_LxvP_1 | 127 | 130 | PF13499 | 0.417 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.370 |
DOC_WW_Pin1_4 | 70 | 75 | PF00397 | 0.649 |
LIG_14-3-3_CanoR_1 | 102 | 112 | PF00244 | 0.487 |
LIG_14-3-3_CanoR_1 | 9 | 17 | PF00244 | 0.666 |
LIG_APCC_ABBA_1 | 270 | 275 | PF00400 | 0.378 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.616 |
LIG_BIR_III_2 | 245 | 249 | PF00653 | 0.362 |
LIG_deltaCOP1_diTrp_1 | 46 | 52 | PF00928 | 0.411 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.487 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.392 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.487 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.636 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.484 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.523 |
LIG_FHA_2 | 224 | 230 | PF00498 | 0.342 |
LIG_FHA_2 | 3 | 9 | PF00498 | 0.529 |
LIG_LIR_Gen_1 | 128 | 135 | PF02991 | 0.432 |
LIG_LIR_Gen_1 | 191 | 201 | PF02991 | 0.386 |
LIG_LIR_Gen_1 | 268 | 276 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 148 | 152 | PF02991 | 0.232 |
LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 268 | 273 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 70 | 75 | PF02991 | 0.608 |
LIG_Pex14_1 | 47 | 51 | PF04695 | 0.266 |
LIG_Pex14_2 | 194 | 198 | PF04695 | 0.369 |
LIG_PTB_Apo_2 | 217 | 224 | PF02174 | 0.399 |
LIG_PTB_Phospho_1 | 217 | 223 | PF10480 | 0.391 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.693 |
LIG_SH2_STAP1 | 253 | 257 | PF00017 | 0.353 |
LIG_SH2_STAP1 | 32 | 36 | PF00017 | 0.266 |
LIG_SH2_STAT3 | 162 | 165 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.339 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.483 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.280 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.648 |
LIG_SH3_3 | 73 | 79 | PF00018 | 0.580 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.623 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.472 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.659 |
MOD_CK2_1 | 130 | 136 | PF00069 | 0.521 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.548 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.617 |
MOD_GlcNHglycan | 136 | 142 | PF01048 | 0.561 |
MOD_GlcNHglycan | 46 | 50 | PF01048 | 0.270 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.512 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.383 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.445 |
MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.411 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.300 |
MOD_NEK2_2 | 178 | 183 | PF00069 | 0.375 |
MOD_PIKK_1 | 10 | 16 | PF00454 | 0.665 |
MOD_Plk_1 | 167 | 173 | PF00069 | 0.406 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.551 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.556 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.363 |
MOD_ProDKin_1 | 70 | 76 | PF00069 | 0.645 |
TRG_DiLeu_BaLyEn_6 | 196 | 201 | PF01217 | 0.485 |
TRG_DiLeu_BaLyEn_6 | 205 | 210 | PF01217 | 0.487 |
TRG_DiLeu_BaLyEn_6 | 260 | 265 | PF01217 | 0.336 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.360 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.648 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.413 |
TRG_NES_CRM1_1 | 189 | 203 | PF08389 | 0.389 |
TRG_NES_CRM1_1 | 256 | 268 | PF08389 | 0.331 |
TRG_Pf-PMV_PEXEL_1 | 110 | 114 | PF00026 | 0.409 |
TRG_Pf-PMV_PEXEL_1 | 199 | 203 | PF00026 | 0.496 |
TRG_Pf-PMV_PEXEL_1 | 208 | 212 | PF00026 | 0.498 |
TRG_Pf-PMV_PEXEL_1 | 231 | 236 | PF00026 | 0.271 |
TRG_Pf-PMV_PEXEL_1 | 263 | 268 | PF00026 | 0.336 |
TRG_Pf-PMV_PEXEL_1 | 9 | 14 | PF00026 | 0.665 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJL0 | Leptomonas seymouri | 71% | 98% |
A0A0S4IX78 | Bodo saltans | 47% | 100% |
A0A1X0P532 | Trypanosomatidae | 55% | 100% |
A0A3Q8IJR7 | Leishmania donovani | 96% | 100% |
A0A422NK65 | Trypanosoma rangeli | 49% | 100% |
A4HN77 | Leishmania braziliensis | 89% | 100% |
A4IBU5 | Leishmania infantum | 95% | 100% |
C9ZYR7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AFN2 | Leishmania major | 96% | 100% |
V5C2Q7 | Trypanosoma cruzi | 52% | 100% |